![Catherine Mathis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Catherine Mathis
Plus aucun poste en cours
Profil
Catherine Mathis served as Director of Regulatory Affairs at Transgene SA from 1994 to 2014.
She then worked as Senior Director of Regulatory Affairs at Voisin Consulting, Inc. in 2014-2015.
In 2016, she became Vice President of Regulatory Affairs at Sangamo Therapeutics France SAS, and later that year, she became the Chief Operating Officer at ElsaLys Biotech SAS, where she worked until 2019.
Dr. Mathis holds a graduate degree from Université Paris 1 Panthéon-Sorbonne and a doctorate from Université de Paris 5 René Descartes.
Anciens postes connus de Catherine Mathis
| Sociétés | Poste | Fin |
|---|---|---|
| ELSALYS BIOTECH | Directeur des opérations | 01/02/2019 |
| TXCELL | Conseiller Juridique Général | 01/09/2016 |
Voisin Consulting, Inc.
 Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development consulting services | Conseiller Juridique Général | 01/12/2015 |
| TRANSGENE | Conseiller Juridique Général | 01/10/2014 |
Formation de Catherine Mathis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Université Paris 1 Panthéon-Sorbonne
 Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
Université de Paris 5 René Descartes
 Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology Designs, develops and supplies antibodies to modulate the immune system of patients | Health Technology |
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development consulting services | Commercial Services |
